Anil Kumar, MD
Cardiovascular Disease · Prescott Valley, AZNPI 1366691552
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (55.9%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Medtronic accounts for 64.9% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $4,082 and has fallen 98.4% since, to $64 in 2024.
Across 49 payments — averaging $207.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$7K
- Bard Peripheral Vascular, Inc.$3K
- Biocompatibles, Inc.$167
- Melinta Therapeutics, LLC$125
- AbbVie$120
- Novartis$113
- plus $309 from 8 others
Across 16 payments — averaging $9725.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$156K
What the payments were for
- Consulting fees$2,01320%
- Speaking & faculty fees$5,68856%
- Travel & lodging$1,11311%
- Food & beverage$1,36813%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 13 | $6,609 |
| Bard Peripheral Vascular, Inc. | 6 | $2,739 |
| Biocompatibles, Inc. | 4 | $167 |
| Melinta Therapeutics, LLC | 1 | $125 |
| AbbVie | 1 | $120 |
| Novartis | 6 | $113 |
| Boston Scientific | 5 | $88 |
| Johnson & Johnson | 5 | $82 |
| Tactile Systems Technology Inc | 3 | $53 |
| Organogenesis Inc. | 1 | $21 |
| Venclose Inc. | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Cardiovascular Systems Inc. | 1 | $15 |
| Convatec Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VenaSeal$3,360
- ClosureFast$3,065
- Venclose Maven Catheter$436
- Vabomere$125
- VENOVO$124
- VARITHENA$122
- DALVANCE$120
How this compares
$10,182 in reported general payments places this provider in the 75th percentile of 423 cardiovascular disease providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 16 | $14,523 |
| Prasugrel Hcl | 13 | $3,178 |
| Metoprolol Succinate | 91 | $887 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 17 | $296 |
| Atorvastatin Calcium | 44 | $236 |
| Spironolactone | 25 | $145 |
| Ezetimibe | 14 | $131 |
| Digoxin | 11 | $122 |
| Amlodipine Besylate | 47 | $113 |
| Rosuvastatin Calcium | 19 | $110 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 17 | $110 |
| Losartan Potassium | 37 | $91 |
| Furosemide | 22 | $62 |
| Lisinopril | 24 | $36 |
| Carvedilol | 16 | $34 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Prescott Valley
- Ashish GuptaPhoenix$1.1M
- Rajkumar SugumaranPhoenix$957K
- Krishnaswami VijayaraghavanScottsdale$927K
- Steven MottlTucson$340K
- Paul UnderwoodScottsdale$259K
- Omar WaniFlagstaff$244K
- Robert BurkeScottsdale$207K
- Andrew KaplanMesa$204K
- Tabitha MoePhoenix$182K
- Karl KernTucson$174K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.